Guru Ownership Trend
Guru Analysis for Zevra Therapeutics, Inc. (ZVRA)
Zevra Therapeutics, Inc. (ZVRA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $35.63 M.
Top institutional holders include Steven Cohen and Chuck Royce.
Institutional sentiment is currently Bullish. This is evidenced by a $7.59 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 55.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Zevra Therapeutics, Inc. (ZVRA)
Major holders include Steven Cohen ($10.78 M), Chuck Royce ($9.21 M), Paul Tudor Jones ($4.13 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.67 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $7.59 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ZVRA. The total reported sell value was $4.34 M.
Yes, 1 managers opened new positions in ZVRA, and 1 increased their existing holdings. The total reported buy value was $11.93 M.